Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to -$1.6 million.

  • Rockwell Medical's Free Cash Flow fell 13883.45% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 21332.07%. This contributed to the annual value of $3.2 million for FY2024, which is 13291.05% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Free Cash Flow is -$1.6 million, which was down 13883.45% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Free Cash Flow ranged from a high of $4.1 million in Q3 2024 and a low of -$12.5 million during Q1 2021
  • Over the past 5 years, Rockwell Medical's median Free Cash Flow value was -$2.5 million (recorded in 2024), while the average stood at -$3.2 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first crashed by 26878.67% in 2023, then surged by 64651.16% in 2024.
  • Rockwell Medical's Free Cash Flow (Quarter) stood at -$9.1 million in 2021, then skyrocketed by 95.7% to -$393000.0 in 2022, then skyrocketed by 78.12% to -$86000.0 in 2023, then soared by 646.51% to $470000.0 in 2024, then crashed by 437.45% to -$1.6 million in 2025.
  • Its Free Cash Flow stands at -$1.6 million for Q3 2025, versus $1.7 million for Q2 2025 and -$3.6 million for Q1 2025.